Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting, 62112 [E6-17660]

Download as PDF 62112 Federal Register / Vol. 71, No. 204 / Monday, October 23, 2006 / Notices the NTP BSC (see FOR FURTHER INFORMATION CONTACT above) by November 17, 2006, to enable review by the NTP BSC and NIEHS/NTP staff prior to the meeting. Written statements can supplement and may expand the oral presentation. If registering on-site and reading from written text, please bring 40 copies of the statement for distribution to the NTP BSC and NIEHS/ NTP staff and to supplement the record. Written comments received in response to this notice will be posted on the NTP Web site. Persons submitting written comments should include their name, affiliation, mailing address, phone, fax, e-mail, and sponsoring organization (if any) with the document. Background Information on the NTP Board of Scientific Counselors The NTP BSC is a technical advisory body comprised of scientists from the public and private sectors who provide primary scientific oversight to the overall program and its centers. Specifically, the NTP BSC advises the NTP on matters of scientific program content, both present and future, and conducts periodic review of the program for the purposes of determining and advising on the scientific merit of its activities and their overall scientific quality. Its members are selected from recognized authorities knowledgeable in fields such as toxicology, pharmacology, pathology, biochemistry, epidemiology, risk assessment, carcinogenesis, mutagenesis, molecular biology, behavioral toxicology and neurotoxicology, immunotoxicology, reproductive toxicology or teratology, and biostatistics. Members serve overlapping terms of up to four years. NTP BSC meetings are held annually or biannually. Dated: October 13, 2006. Samuel A. Wilson, Deputy Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E6–17711 Filed 10–20–06; 8:45 am] Control and Prevention (CDC) announces the following meeting. Name: Healthcare Infection Control Practices Advisory Committee (HICPAC). Times And Dates: 8:30 a.m.–5 p.m., November 13, 2006; 8:30 a.m.–4 p.m., November 14, 2006. Place: CDC Roybal Campus, Bldg 19, Auditorium B3, 1600 Clifton Road, Atlanta, GA 30333. Status: Open to the public, limited only by the space available. Purpose: The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Infectious Diseases (NCID), regarding (1) the practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: Agenda items will include: Issues related to public reporting of healthcare-associated infection rates; Infection control for multi-drug resistant organisms; and, topics related to future guidelines. Agenda items are subject to change as priorities dictate. Contact Person For More Information: Harriette Lynch, Committee Management Specialist, HICPAC, Division of Healthcare Quality Promotion, NCID, CDC, l600 Clifton Road, NE., M/S A–07, Atlanta, Georgia 30333, telephone 404/639–4035. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: October 16, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–17660 Filed 10–20–06; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4140–01–P mstockstill on PROD1PC76 with NOTICES Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Jkt 211001 BILLING CODE 4163–18–P Centers for Disease Control and Prevention Centers for Disease Control and Prevention 15:50 Oct 20, 2006 Dated: October 16, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–17652 Filed 10–20–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Aug<31>2005 Name: Advisory Council for the Elimination of Tuberculosis (ACET). Times and Dates: 8:30 a.m.–5 p.m., December 5, 2006; 8:30 a.m.–12 p.m., December 6, 2006. Place: Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis (TB). Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating TB. Matters to be Discussed: Agenda items include issues pertaining to Emerging Global issues in TB Surveillance and Control; XDR-TB: Implications for TB control in the U.S.; TB among Foreignborn and other related tuberculosis issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Loretta Coleman-Johnson, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., M/S E–10, Atlanta, Georgia 30333, Telephone 404/ 639–8120. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Council for the Elimination of Tuberculosis Health Resources and Services Administration In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following council meeting: Agency Information Collection Activities: Submission for OMB Review; Comment Request PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Periodically, the Health Resources and Services Administration (HRSA) E:\FR\FM\23OCN1.SGM 23OCN1

Agencies

[Federal Register Volume 71, Number 204 (Monday, October 23, 2006)]
[Notices]
[Page 62112]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-17660]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC): Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Healthcare Infection Control Practices Advisory Committee 
(HICPAC).
    Times And Dates: 8:30 a.m.-5 p.m., November 13, 2006; 8:30 a.m.-
4 p.m., November 14, 2006.
    Place: CDC Roybal Campus, Bldg 19, Auditorium B3, 1600 Clifton 
Road, Atlanta, GA 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, the Assistant Secretary for Health, the 
Director, CDC, and the Director, National Center for Infectious 
Diseases (NCID), regarding (1) the practice of hospital infection 
control; (2) strategies for surveillance, prevention, and control of 
infections (e.g., nosocomial infections), antimicrobial resistance, 
and related events in settings where healthcare is provided; and (3) 
periodic updating of guidelines and other policy statements 
regarding prevention of healthcare-associated infections and 
healthcare-related conditions.
    Matters To Be Discussed: Agenda items will include: Issues 
related to public reporting of healthcare-associated infection 
rates; Infection control for multi-drug resistant organisms; and, 
topics related to future guidelines.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Harriette Lynch, Committee 
Management Specialist, HICPAC, Division of Healthcare Quality 
Promotion, NCID, CDC, l600 Clifton Road, NE., M/S A-07, Atlanta, 
Georgia 30333, telephone 404/639-4035.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: October 16, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-17660 Filed 10-20-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.